Platinum-Free Break Enhances Therapy After First Relapse In Ovarian Cancer
Majority Of Americans Would Consider Participating In Clinical Trials, Study Finds
Mesothelioma Survival, QOL Improved With Alimta, Platinol
NCI-Funded Trials Show Aspirin Reduces Recurrence of Polyps
Study Finds Green Tea No Help In Advanced Prostate Cancer
Cancer Screening Priorities Questioned In Dartmouth Study
Regular NSAIDs Use Protects Smokers From Lung Cancer
Women Are Less Active After A Diagnosis of Breast Cancer
NCI-Approved Protocols Listed
Trending Stories
- An opportunity for Trump: Position U.S. cancer science to lead the world
- Former Maryland Governor Larry Hogan to receive Public Service Leadership Award from National Coalition for Cancer Survivorship
- The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear” - Grilled by Congress, Kennedy defends NIH and NCI budget cuts, freezes, and RIFs
To avoid “offending” pharma, NCI doesn’t study the causes of early-onset colon cancer, HHS secretary incorrectly alleges - NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - Kennedy’s claims notwithstanding, NCI clinical trials are delayed, enrollments reduced
NCI’s Steven A. Rosenberg: “Almost all patients are getting delayed by about a month, but then again, we’re turning away more patients.”
